Efficacy and Tolerability of Rifaximin in Combination With Lactulose in End-stage Liver Disease Patients With MELD Greater Than 20: A Single Center Experience
2014 ◽
Vol 46
(10)
◽
pp. 3481-3486
◽
Keyword(s):